Ebola in the DRC
Gavi is closely monitoring the Ebola disease outbreak caused by Bundibugyo virus that is currently affecting the Democratic Republic of the Congo and Uganda.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreWhat happened to the feared ‘subclade K’ flu strain?
Scientists say that measuring human immunity alongside existing methods could improve predictions of the risks posed by emerging flu strains.
In Nigeria, immunisation days become nutrition school for parents
In Ebonyi State, Nigeria, a youth-led initiative is transforming routine immunisation clinics into platforms for combatting child malnutrition.
AI shows promise in the fight against fake news
In an epidemic of online misinformation, experts look to artificial intelligence to help sort fact from fiction.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allGavi Board meeting underlines commitment to country sovereignty, fragility and health security
Board agrees to maintain ambitious targets for Gavi 6.0, including reaching 500 million children, preventing 8-9 million deaths, and further reducing under-five mortality by 10%.
Gavi launches new supply chain strategy to boost vaccine availability and reach remote communities
New immunisation Supply Chain Strategy seeks to build on recent years’ momentum and help countries ensure vaccines reliably reach people safely, reliably and on time – including under-served communities.
Partnership agreement between Gavi and the OPEC Fund will help scale up sustainable health financing across 47 eligible countries.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
